Development of an electronic medical record based alert for risk of HIV treatment failure in a low-resource setting

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Puttkammer, Nancy ^a   Zeliadt, Steven ^a   Balan, Jean Gabriel ^b   Baseman, Janet ^a   Destiné, Rodney ^b   Domercant, Jean Wysler ^c   France, Garilus ^d   Hyppolite, Nathaelf ^b   Pelletier, Valérie ^c   Raphael, Nernst Atwood ^b   Sherr, Kenneth ^e   Yuhas, Krista ^a   Barnhart, Scott ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b International Training and Education Center for Health   (Haïti)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Ministry of Public Health and Population   (Haïti)

^e HEALTH ALLIANCE INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGE; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HAITI; HIGH RISK POPULATION; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICATION COMPLIANCE; MEDICATION POSSESSION RATIO; NO MISSED DOSES; PATIENT COMPLIANCE; PHARMACY; PREDICTION; PROPORTION OF DAYS COVERED; RECEIVER OPERATING CHARACTERISTIC; RESIDENTIAL AREA; RISK SCORE; SCORING SYSTEM; SELF REPORT; SENSITIVITY ANALYSIS; SEX; TIMELY VISIT RATIO; TREATMENT DURATION; TREATMENT FAILURE; VISUAL ANALOG SCALE; WORLD HEALTH ORGANIZATION; HEALTH CARE PLANNING; HIV INFECTIONS; MIDDLE AGED; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; AREA UNDER CURVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK; ROC CURVE; TREATMENT FAILURE; YOUNG ADULT;

EID: 84911478626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112261     Document Type: Article

References (44)

1. Chaiyachati K, Hirschhorn LR, Tanser F, Newell M-L, Ba? rnighausen T (2011) Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa. AIDS Patient Care and STDs 25(3): 163-170.
2. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, et al. (2006) Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. Aids and Behavior 10: 227-245.
3. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, et al. (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care 12: 255-266.
4. Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, et al. (2012) Guidelines for improving entry into and retention in care and antiretroviral adherence for persons With HIV: Evidence-based recommendations from an International Association of Physicians in AIDS Care. Panel Ann Intern Med 156: 817-833.
5. Liu H, Golin CE, Miller LG, Hays RD, Beck K, et al. (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134: 968-977.
6. Kunutsor S, Evans M, Thoulass J, Walley J, Katabira E, et al. (2010) Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: A multimethod approach. J Acquir Immune Defic Syndr 55: 221-224.
7. Garfield S, Clifford S, Eliasson L, Barber N, Willson A (2011) Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review. BMC Medical Research Methodology 11: 149-158.
8. McMahon JH, Manoharan A, Wanke CA, Mammen S, Jose H, et al. (2013) Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India. Aids and Behavior 17: 2253-2259.
9. McMahon JH, Jordan MR, Kelley K, Bertagnolio S, Hong SY, et al. (2011) Pharmacy adherence measures to assess adherence to antiretroviral therapy: Review of the literature and implications for treatment monitoring. Clinical Infectious Diseases 52: 493-506.
10. Cayemittes M, Busangu MF, Bizimana JdD, Barrère B, Se?vère B, et al. (2013) Enque?te Mortalite?, Morbidite? et Utilisation des Services (EMMUS-V): Haiti Intitut Haitien d'Enfance and Measure DHS. Available: http:// dhsprogram.com/publications/publication-fr273-dhs-final-reports.cfm. Accessed 20 Oct 2014.
11. Matheson AI, Baseman JG, Wagner SH, O'Malley GE, Puttkammer NH, et al. (2012) Implementation and expansion of an electronic medical record for HIV care and treatment in Haiti: an assessment of system use and the impact of largescale disruptions. International Journal of Medical Informatics 81: 244-256.
12. Lober W, Quiles C, Wagner S, Cassagnol R, Lamothes R, et al. (2008) Three years experience with the implementation of a networked electronic medical record in Haiti. AMIA Annual Symposium Proceedings Nov 6: 434-438.
13. MSPP/PNLS (2012) De?claration d'Engagement sur le VIH/SIDA: Rapport de Situation National UNGASS. Ministère de la Sante? Publique et de la Population, Programme National de Lutte contre le SIDA. Available: http:// www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce-HT-Narrative-Report%5B1%5D.pdf. Accessed 2014 October 20.
14. Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF (2013) Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care 51: S11-S21.
15. Hess LM (2006) Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. Annals of Pharmacotherapy 40: 1280-1288.
16. Chu L-H, Kawatkar A, Gu A A SAS macro program to calculate medication adherence rate for single and multiple medication use. Kaiser Permanente.
17. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR (2004) Measuring adherence to antiretroviral therapy in a diverse population asing a visual analogue scale. HIV Clin Trials 5: 74-79.
18. World Health Organization (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/. Accessed 2014 October 20.
19. Balan JG (2013) Clinical question related to ART analysis [Personal communication to Puttkammer N]. Seattle: I-TECH, University of Washington.
20. Puttkammer N, Raphael A, Zamor G (2013) iSante? data validation exercise [Internal report]. Seattle: I-TECH, University of Washington.
21. Pepe MS (2003) The statistical evaluation of medical tests for classification and prediction. King's Lynn, Norfolk: Oxford University Press.
22. Pepe MS, Longton G, Janes H (2009) Estimation and comparison of receiver operating characteristic curves. The Stata Journal 9: 1-16.
23. Altman DG, Vergouwe Y, Royston P, Moons KGM (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338: b605-b605.
24. Burnham KP (2004) Multimodel inference: Understanding AIC and BIC in model selection. Sociological Methods & Research 33: 261-304.
25. Fan VS, Au D, Heagerty P, Deyo RA, McDonell MB, et al. (2002) Validation of case-mix measures derived from self-reports of diagnoses and health. Journal of Clinical Epidemiology 55: 371-380.
26. Wand H, Guy R, Donovan B, McNulty A (2011) Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia. BMJ Open 1: e000005.
27. Plews I (2010) Constructing and applying risk scores in the social sciences. University of Manchester. Available: http://www.cmist.manchester.ac.uk/ research/publications/working-papers/2010/. Accessed 2014 October 20.
28. Hosmer DW, Lemeshow S (2000) Applied logistic regression. New York: Wiley.
29. nd Edition New York: Wiley.
30. Puttkammer N, Zeliadt S, Domercant JW, Labbe? Coq NR, Raphael NA, et al. (2013) Using an electronic medical record system to identify factors associated with ART attrition at 2 hospitals in Haiti. International Training and Education Center for Health (I-TECH), University of Washington.
31. Koenig SP, Rodriguez LA, Bartholomew C, Edwards A, Carmichael TE, et al. (2012) Long-term antiretroviral treatment outcomes in seven countries in the Caribbean. Journal of Acquired Immune Deficiency Syndromes 59: e60-71.
32. Amico KR, Orrell C (2013) Antiretroviral therapy adherence support: Recommendations and future directions. Journal of the International Association of Physicians in AIDS Care (JIAPAC) 12: 128-137.
33. Oluoch T, Santas X, Kwaro D, Were M, Biondich P, et al. (2012) The effect of electronic medical record-based clinical decision support on HIV care in resource-constrained settings: A systematic review. International Journal of Medical Informatics 81: e83-e92.
34. Robbins GK, Lester W, Johnson KL, Chang Y, Estey G, et al. (2012) Efficacy of a clinical decision-support system in an HIV practice. Annals of Internal Medicine 157: 757-766.
35. Pearson S-A, Moxey A, Robertson J, Hains I, Williamson M, et al. (2009) Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Services Research 9: 1-14.
36. Damiani G, Pinnarelli L, Colosimo SC, Almiento R, Sicuro L, et al. (2010) The effectiveness of computerized clinical guidelines in the process of care: a systematic review. BMC Health Services Research 10: 1-11.
37. Were MC, Shen C, Tierney WM, Mamlin JJ, Biondich PG, et al. (2011) Evaluation of computer-generated reminders to improve CD4 laboratory monitoring in sub-Saharan Africa: a prospective comparative study. Journal of the American Medical Informatics Association 18: 150-155.
38. Robbins Gregory K, Johnson Kristin L, Chang Y, Jackson Katherine E, Sax Paul E, et al. (2010) Predicting virologic failure in an HIV clinic. Clinical Infectious Diseases 50: 779-786.
39. Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, et al. (2008) Pharmacy refill adherence compared with CD4 count changes for monitoring HIVinfected adults on antiretroviral therapy. PLoS Med 5: 777-789.
40. Gsponer T, Petersen M, Egger M, Phiri S, Maathuis MH, et al. (2012) The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring. Aids 26: 57-65.
41. Keiser O, MacPhail P, Boulle A, Wood R, Schechter M, et al. (2009) Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Tropical Medicine & International Health 14: 1220-1225.
42. van Oosterhout JJG, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, et al. (2009) Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Tropical Medicine & International Health 14: 856-861.
43. Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD (2008) Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. Aids 22: 1971-1977.
44. Charles M, Noel F, Leger P, Severe P, Riviere C, et al. (2008) Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. Bulletin of the World Health Organization 86: 970-977.